Skip to main content
CivicGate

HRES 1167
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

Expressing support for the designation of the month of April 2026 as "Parkinson's Awareness Month".

Expressing support for the designation of the month of April 2026 as ``Parkinson's Awareness Month''.

Introduced Apr 14, 2026

Latest action (Apr 14, 2026) Referred to the House Committee on Energy and Commerce.

Policy area
Issues
Healthcare

Summary

This resolution expresses the House of Representatives' support for designating April 2026 as "Parkinson's Awareness Month." The resolution acknowledges the impact of Parkinson's disease, which affects over one million Americans, and recognizes the efforts of organizations, researchers, and volunteers working on treatments and support services. The resolution reaffirms congressional support for research to find better treatments and a cure for the disease.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)

Actions (2)

  1. Apr 14, 2026 Referred to the House Committee on Energy and Commerce. · house
  2. Apr 14, 2026 Submitted in House

Similar bills (6)

Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.

Full text

IN THE HOUSE OF REPRESENTATIVES

April 14, 2026

Mr. Bell (for himself and Mr. Bilirakis) submitted the following resolution; which was referred to the Committee on Energy and Commerce

RESOLUTION

Expressing support for the designation of the month of April 2026 as “Parkinson’s Awareness Month”.

Whereas Parkinson’s disease—

(1) affects over 1,000,000 individuals in the United States with nearly 90,000 individuals diagnosed each year;

(2) is the fastest-growing and second most common neurodegenerative disease in the world;

(3) is believed to be caused by a combination of genetic and environmental factors, but the exact cause in most individuals is still unknown; and

(4) is the 13th leading cause of death in the United States, according to the Centers for Disease Control and Prevention;

Whereas, by the year 2045, it is estimated that the number of individuals in the United States with Parkinson’s disease and related conditions will reach 1,700,000, and will cost the United States $112,400,000,000; Whereas the symptoms of Parkinson’s disease can include dementia and cognitive impairment, tremors, slowness of movement and rigidity, gait and balance difficulties, speech and swallowing difficulties, depression, and a variety of other symptoms; Whereas there are millions of family caregivers, friends, and loved ones whose lives are greatly affected by Parkinson’s disease, and recent analysis shows care partners of those facing Parkinson’s shouldered $8,300,000,000 in lost earnings and productivity due to reduced work hours and early retirement in 2024; and Whereas more research, education, and community support services are needed—

(1) to find better treatments and a cure for Parkinson’s disease; and

(2) to maintain the dignity of individuals living with Parkinson’s disease: Now, therefore, be it

Resolved, That the House of Representatives—

(1) expresses support for the designation of “Parkinson’s Awareness Month”;

(2) supports the goals and ideals of Parkinson’s Awareness Month;

(3) continues to support research to find better treatments and a cure for Parkinson’s disease;

(4) recognizes the individuals living with Parkinson’s disease who participate in vital clinical trials to advance the knowledge of the disease; and

(5) commends the dedication of organizations, volunteers, researchers, and millions of individuals across the United States working to improve the quality of life of people living with Parkinson’s disease and their families. <all>

Comments

Comments

Loading comments…